These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17186232)

  • 1. "Hair-on-end" skull induced by long-term G-CSF treatment in severe congenital neutropenia.
    Albert MH; Notheis G; Wintergerst U; Born C; Schneider K
    Pediatr Radiol; 2007 Feb; 37(2):221-4. PubMed ID: 17186232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoporosis in severe congenital neutropenia: inherent to the disease or a sequela of G-CSF treatment?
    Simon M; Lengfelder E; Reiter S; Hehlmann R
    Am J Hematol; 1996 Jun; 52(2):127. PubMed ID: 8638643
    [No Abstract]   [Full Text] [Related]  

  • 3. Osteoporosis in severe congenital neutropenia treated with granulocyte colony-stimulating factor.
    Bishop NJ; Williams DM; Compston JC; Stirling DM; Prentice A
    Br J Haematol; 1995 Apr; 89(4):927-8. PubMed ID: 7539627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MPGN type I induced by granulocyte colony stimulating factor.
    Magen D; Mandel H; Berant M; Ben-Izhak O; Zelikovic I
    Pediatr Nephrol; 2002 May; 17(5):370-2. PubMed ID: 12042897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant myeloid transformation in congenital forms of neutropenia.
    Freedman MH; Alter BP
    Isr Med Assoc J; 2002 Nov; 4(11):1011-4. PubMed ID: 12489493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trisomy 21 and isodicentric chromosome 21 in Kostmann syndrome following treatment with G-CSF.
    Roland B; Woodman RC; Jorgenson K; Pinto A
    Cancer Genet Cytogenet; 2001 Apr; 126(1):78-80. PubMed ID: 11343785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bullous Sweet's syndrome after granulocyte colony-stimulating factor therapy in a child with congenital neutropenia.
    Akilov OE; Desai N; Jaffe R; Gehris RP
    Pediatr Dermatol; 2014; 31(2):e61-2. PubMed ID: 24387761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocytoclastic vasculitis in patients with severe congenital neutropenia.
    Kilic SS; Mustafayeva S; Ipek K; Adim SB
    J Trop Pediatr; 2010 Oct; 56(5):359-62. PubMed ID: 20100783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia.
    Dong F; Brynes RK; Tidow N; Welte K; Löwenberg B; Touw IP
    N Engl J Med; 1995 Aug; 333(8):487-93. PubMed ID: 7542747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinamide (vitamin B3) treatment improves response to G-CSF in severe congenital neutropenia patients.
    Deordieva E; Shvets O; Voronin K; Maschan A; Welte K; Skokowa J; Novichkova G; Shcherbina A
    Br J Haematol; 2021 Feb; 192(4):788-792. PubMed ID: 33471934
    [No Abstract]   [Full Text] [Related]  

  • 12. [Molecular analysis of two cases of severe congenital neutropenia].
    Park J; Kim M; Lim J; Kim Y; Cho B; Park YJ; Han K
    Korean J Lab Med; 2010 Apr; 30(2):111-6. PubMed ID: 20445326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Leukemogenic risk during long-term use of G-CSF in constitutional neutropenia].
    Donadieu J
    Arch Fr Pediatr; 1993 Nov; 50(9):827. PubMed ID: 7520227
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group.
    Donadieu J; Leblanc T; Bader Meunier B; Barkaoui M; Fenneteau O; Bertrand Y; Maier-Redelsperger M; Micheau M; Stephan JL; Phillipe N; Bordigoni P; Babin-Boilletot A; Bensaid P; Manel AM; Vilmer E; Thuret I; Blanche S; Gluckman E; Fischer A; Mechinaud F; Joly B; Lamy T; Hermine O; Cassinat B; Bellanné-Chantelot C; Chomienne C;
    Haematologica; 2005 Jan; 90(1):45-53. PubMed ID: 15642668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Term delivery in a woman with severe congenital neutropenia, treated with growth colony stimulating factor.
    Kaufmann SJ; Sharif K; Sharma V; McVerry BA
    Hum Reprod; 1998 Feb; 13(2):498-9. PubMed ID: 9557864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [GM-CSF and G-CSF: cytokines in clinical application].
    Ruef C; Coleman DL
    Schweiz Med Wochenschr; 1991 Mar; 121(12):397-412. PubMed ID: 1709294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term treatment with recombinant human granulocyte colony stimulating factor in patients with severe congenital neutropenia].
    Zeidler C; Reiter A; Yakisan E; Koci B; Riehm H; Welte K
    Klin Padiatr; 1993; 205(4):264-71. PubMed ID: 7690865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chemotherapy-induced neutropenia in a rat model by using multiple daily doses of oral administration of G-CSF-containing nanoparticles.
    Su FY; Chuang EY; Lin PY; Chou YC; Chen CT; Mi FL; Wey SP; Yen TC; Lin KJ; Sung HW
    Biomaterials; 2014 Apr; 35(11):3641-9. PubMed ID: 24477192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
    McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
    Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic congenital neutropenia treated with granulocyte colony-stimulating factor (G-CSF)].
    Jonsbo F
    Ugeskr Laeger; 1992 Feb; 154(8):492-3. PubMed ID: 1371630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.